Product Details for: BEQVEZ
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Suspension
Intravenous
1x E13 VG/ML
Single-Dose Vial
351(a)
BEQVEZ
Disc
Proper Name
fidanacogene elaparvovec-dzkt
fidanacogene elaparvovec-dzkt
BLA Number
125786
125786
Applicant
Pfizer Inc.
Pfizer Inc.
Original Approval Date
April 25, 2024
April 25, 2024
Date of First Licensure
04/25/2024
04/25/2024